Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

Abroad (travel likely)Recruiting

Conditions

Stage IV Esophageal Adenocarcinoma · Stage IV Esophageal Squamous Cell Carcinoma · Stage IV Gastric Cancer · Stage IV Adenocarcinoma of the Gastroesophageal Junction · Stage IVA Esophageal Adenocarcinoma · Stage IVA Esophageal Squamous Cell Carcinoma · Stage IVA Gastric Cancer · Stage IVA Adenocarcinoma of the Gastroesophageal Junction · Stage IVB Esophageal Adenocarcinoma · Stage IVB Esophageal Squamous Cell Carcinoma · Stage IVB Gastric Cancer · Stage IVB Gastroesophageal Junction Adenocarcinoma · Metastatic Anal Canal Carcinoma · Metastatic Colorectal Carcinoma · Metastatic Esophageal Carcinoma · Metastatic Gastric Carcinoma · Metastatic Gastroesophageal Junction Adenocarcinoma · Metastatic Hepatocellular Carcinoma · Metastatic Malignant Digestive System Neoplasm · Metastatic Small Intestinal Carcinoma · Pancreatobiliary Carcinoma · Pathologic Stage IV Gastric Cancer AJCC v8 · Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8 · Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8 · Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8 · Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8 · Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 · Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8 · Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8 · Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 · Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8 · Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8 · Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 · Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8 · Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC V8 · Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 · Stage IV Anal Cancer AJCC v8 · Stage IV Colorectal Cancer AJCC v8 · Stage IV Hepatocellular Carcinoma AJCC v8 · Stage IVA Colorectal Cancer AJCC v8 · Stage IVA Hepatocellular Carcinoma AJCC v8 · Stage IVB Colorectal Cancer AJCC v8 · Stage IVB Hepatocellular Carcinoma AJCC v8 · Stage IVC Colorectal Cancer AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of California, San Francisco, San Francisco, California, United States
Contact: Study coordinator (Luchia Andemicael) · luchia.andemicael@ucsf.edu · 415-530-9814
Study coordinator · cancertrials@ucsf.edu · 877-827-3222
Contact: Principal Investigator (Mary Feng, MD)
John Muir Medical Center-Walnut Creek, Walnut Creek, California, United States
Contact: Principal Investigator (Sravan Chennupati, MD)

Study leads

Mary Feng, MD
Principal Investigator
University of California, San Francisco

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

Gastric Adenocarcinoma · Oligometastasis · Stage IV Esophageal Adenocarcinoma AJCC v7

Abroad (travel likely)RecruitingPHASE2

Houston, United States

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Advanced Esophageal Squamous Cell Carcinoma · Advanced Renal Cell Carcinoma · Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8

Abroad (travel likely)RecruitingPHASE2

Jacksonville, United States

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Gastric Cancer · Gastroesophageal Junction Adenocarcinoma · Esophageal Cancer

Abroad (travel likely)RecruitingPHASE3

Mobile, United States · Anchorage, United States

A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma · Esophageal Adenocarcinoma

IsraelRecruitingPHASE2

Duarte, United States · Irvine, United States